ReP USP - Resultado da busca

Artigo de periodico
Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi (2024)
Prates, João Lucas Bruno; Lopes, Juliana Romano ; Chin, Chung Man ; Ferreira, Elizabeth Igne ; Santos, Jean Leandro dos ; Scarim, Cauê Benito
Source: Current Medicinal Chemistry. Unidade: FCF
Subjects: TRYPANOSOMA CRUZI, DOENÇA DE CHAGAS, DESENVOLVIMENTO DE PRODUTOS, PRODUTOS NOVOS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRATES, João Lucas Bruno et al. Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi. Current Medicinal Chemistry, v. 31, n. 16, p. 2285-2308, 2024Tradução . . Disponível em: https://dx.doi.org/10.2174/0109298673254864230921090. Acesso em: 28 abr. 2024.
APA
Prates, J. L. B., Lopes, J. R., Chin, C. M., Ferreira, E. I., Santos, J. L. dos, & Scarim, C. B. (2024). Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi. Current Medicinal Chemistry, 31( 16), 2285-2308. doi:10.2174/0109298673254864230921090
NLM
Prates JLB, Lopes JR, Chin CM, Ferreira EI, Santos JL dos, Scarim CB. Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi [Internet]. Current Medicinal Chemistry. 2024 ; 31( 16): 2285-2308.[citado 2024 abr. 28 ] Available from: https://dx.doi.org/10.2174/0109298673254864230921090
Vancouver
Prates JLB, Lopes JR, Chin CM, Ferreira EI, Santos JL dos, Scarim CB. Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi [Internet]. Current Medicinal Chemistry. 2024 ; 31( 16): 2285-2308.[citado 2024 abr. 28 ] Available from: https://dx.doi.org/10.2174/0109298673254864230921090
Editor de periodico
Current Topics in Medicinal Chemistry (2024)
Zhou, Jia (Editor); Andricopulo, Adriano Defini (Editor) ; Ferreira, Leonardo Luiz Gomes (Editor) ; Garcia, Célia Regina da Silva (Editor)
Unidades: IFSC, FCF
Assunto: QUÍMICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
Current Topics in Medicinal Chemistry. . Sharjah: Bentham Science. . Acesso em: 28 abr. 2024. , 2024
APA
Current Topics in Medicinal Chemistry. (2024). Current Topics in Medicinal Chemistry. Sharjah: Bentham Science.
NLM
Current Topics in Medicinal Chemistry. 2024 ;[citado 2024 abr. 28 ]
Vancouver
Current Topics in Medicinal Chemistry. 2024 ;[citado 2024 abr. 28 ]
Artigo de periodico
Effect of postharvest treatments on the biosynthesis of fruit volatile compounds: a literature review (2023)
Magalhães, Hilton César Rodrigues ; Garruti, Deborah S ; Gandra, Eliezer Avila ; Purgatto, Eduardo
Source: Current Nutrition and Food Science. Unidade: FCF
Subjects: HORMÔNIOS, ÁCIDOS GRAXOS, AMINOÁCIDOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAGALHÃES, Hilton César Rodrigues et al. Effect of postharvest treatments on the biosynthesis of fruit volatile compounds: a literature review. Current Nutrition and Food Science, v. 19, n. 3, p. 246-261, 2023Tradução . . Disponível em: https://doi.org/10.2174/1573401318666220527123341. Acesso em: 28 abr. 2024.
APA
Magalhães, H. C. R., Garruti, D. S., Gandra, E. A., & Purgatto, E. (2023). Effect of postharvest treatments on the biosynthesis of fruit volatile compounds: a literature review. Current Nutrition and Food Science, 19( 3), 246-261. doi:10.2174/1573401318666220527123341
NLM
Magalhães HCR, Garruti DS, Gandra EA, Purgatto E. Effect of postharvest treatments on the biosynthesis of fruit volatile compounds: a literature review [Internet]. Current Nutrition and Food Science. 2023 ; 19( 3): 246-261.[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/1573401318666220527123341
Vancouver
Magalhães HCR, Garruti DS, Gandra EA, Purgatto E. Effect of postharvest treatments on the biosynthesis of fruit volatile compounds: a literature review [Internet]. Current Nutrition and Food Science. 2023 ; 19( 3): 246-261.[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/1573401318666220527123341
Artigo de periodico
Folate pathway inhibitors, an underestimated and underexplored molecular target for new anti-tuberculosis agents (2023)
Vassiliades, Sandra Valeria ; Borges, Lara Gimenez; Giarolla, Jeanine ; Parise Filho, Roberto
Source: Mini-Reviews in Medicinal Chemistry. Unidade: FCF
Subjects: HOMEOSTASE, TUBERCULOSE, ÁCIDO FÓLICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VASSILIADES, Sandra Valeria et al. Folate pathway inhibitors, an underestimated and underexplored molecular target for new anti-tuberculosis agents. Mini-Reviews in Medicinal Chemistry, v. 23, n. 17, p. 1711-1732, 2023Tradução . . Disponível em: https://doi.org/10.2174/1389557523666230206163154. Acesso em: 28 abr. 2024.
APA
Vassiliades, S. V., Borges, L. G., Giarolla, J., & Parise Filho, R. (2023). Folate pathway inhibitors, an underestimated and underexplored molecular target for new anti-tuberculosis agents. Mini-Reviews in Medicinal Chemistry, 23( 17), 1711-1732. doi:10.2174/1389557523666230206163154
NLM
Vassiliades SV, Borges LG, Giarolla J, Parise Filho R. Folate pathway inhibitors, an underestimated and underexplored molecular target for new anti-tuberculosis agents [Internet]. Mini-Reviews in Medicinal Chemistry. 2023 ; 23( 17): 1711-1732.[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/1389557523666230206163154
Vancouver
Vassiliades SV, Borges LG, Giarolla J, Parise Filho R. Folate pathway inhibitors, an underestimated and underexplored molecular target for new anti-tuberculosis agents [Internet]. Mini-Reviews in Medicinal Chemistry. 2023 ; 23( 17): 1711-1732.[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/1389557523666230206163154
Artigo de periodico
2,3-Diarylindoles as COX-2 Inhibitors: exploring the structure-activity relationship through molecular docking simulations (2023)
Cuppoloni, Andréa; Silva, João Vitor da ; Snape, Timothy James ; Lal, Samridhi ; Giarolla, Jeanine
Source: Current Topics in Medicinal Chemistry. Unidade: FCF
Subjects: MEDICAMENTO, METABOLISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CUPPOLONI, Andréa et al. 2,3-Diarylindoles as COX-2 Inhibitors: exploring the structure-activity relationship through molecular docking simulations. Current Topics in Medicinal Chemistry, v. 23, n. 12, p. 1081-1089, 2023Tradução . . Disponível em: https://doi.org/10.2174/1568026623666230207120752. Acesso em: 28 abr. 2024.
APA
Cuppoloni, A., Silva, J. V. da, Snape, T. J., Lal, S., & Giarolla, J. (2023). 2,3-Diarylindoles as COX-2 Inhibitors: exploring the structure-activity relationship through molecular docking simulations. Current Topics in Medicinal Chemistry, 23( 12), 1081-1089. doi:10.2174/1568026623666230207120752
NLM
Cuppoloni A, Silva JV da, Snape TJ, Lal S, Giarolla J. 2,3-Diarylindoles as COX-2 Inhibitors: exploring the structure-activity relationship through molecular docking simulations [Internet]. Current Topics in Medicinal Chemistry. 2023 ; 23( 12): 1081-1089.[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/1568026623666230207120752
Vancouver
Cuppoloni A, Silva JV da, Snape TJ, Lal S, Giarolla J. 2,3-Diarylindoles as COX-2 Inhibitors: exploring the structure-activity relationship through molecular docking simulations [Internet]. Current Topics in Medicinal Chemistry. 2023 ; 23( 12): 1081-1089.[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/1568026623666230207120752
Artigo de periodico
Aryl-isoquinoline as a potential scaffold for novel antitumor agents against glioblastoma cells (2023)
Fernandes, Thais Batista ; Yang, Rosania; Ferreira, Glaucio Monteiro ; Souza, Priscila Oliveira de ; Lopes, Vitor Galvão ; Toledo, Mônica Franco Zannini Junqueira ; Roliano, Gabriela Gonçalves ; Debom, Gabriela Nogueira ; Vassiliades, Sandra Valeria ; Hassimotto, Neuza Mariko Aymoto ; Hirata, Mario Hiroyuki ; Braganhol, Elizandra ; Parise Filho, Roberto
Source: Letters in Drug Design & Discovery. Unidade: FCF
Subjects: GLIOMA, SISTEMA NERVOSO CENTRAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Thais Batista et al. Aryl-isoquinoline as a potential scaffold for novel antitumor agents against glioblastoma cells. Letters in Drug Design & Discovery, 2023Tradução . . Disponível em: https://doi.org/10.2174/1570180820666230131111033. Acesso em: 28 abr. 2024.
APA
Fernandes, T. B., Yang, R., Ferreira, G. M., Souza, P. O. de, Lopes, V. G., Toledo, M. F. Z. J., et al. (2023). Aryl-isoquinoline as a potential scaffold for novel antitumor agents against glioblastoma cells. Letters in Drug Design & Discovery. doi:10.2174/1570180820666230131111033
NLM
Fernandes TB, Yang R, Ferreira GM, Souza PO de, Lopes VG, Toledo MFZJ, Roliano GG, Debom GN, Vassiliades SV, Hassimotto NMA, Hirata MH, Braganhol E, Parise Filho R. Aryl-isoquinoline as a potential scaffold for novel antitumor agents against glioblastoma cells [Internet]. Letters in Drug Design & Discovery. 2023 ;[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/1570180820666230131111033
Vancouver
Fernandes TB, Yang R, Ferreira GM, Souza PO de, Lopes VG, Toledo MFZJ, Roliano GG, Debom GN, Vassiliades SV, Hassimotto NMA, Hirata MH, Braganhol E, Parise Filho R. Aryl-isoquinoline as a potential scaffold for novel antitumor agents against glioblastoma cells [Internet]. Letters in Drug Design & Discovery. 2023 ;[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/1570180820666230131111033
Artigo de periodico
Diagnosis and clinical aspects of lung cancer: a special emphasis on drug targeting to cancer cells through nanoparticles (2023)
Awasthi, Rajendra ; Singh, Anurag Kumar ; Mishra, Gaurav ; Maurya, Anand ; Dhiman, Neerupma ; Kharkwal, Harsha ; Sharma, Bhupesh ; Jha, Niraj Kumar ; Dua, Kamal ; Pinto, Terezinha de Jesus Andreoli ; Kulkarni, Giriraj T
Source: Letters in Drug Design & Discovery. Unidade: FCF
Subjects: NEOPLASIAS PULMONARES, NANOTECNOLOGIA, RESISTÊNCIA MICROBIANA ÀS DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AWASTHI, Rajendra et al. Diagnosis and clinical aspects of lung cancer: a special emphasis on drug targeting to cancer cells through nanoparticles. Letters in Drug Design & Discovery, v. 20, n. 5, p. 499-516, 2023Tradução . . Disponível em: https://doi.org/10.2174/1570180819666220510133408. Acesso em: 28 abr. 2024.
APA
Awasthi, R., Singh, A. K., Mishra, G., Maurya, A., Dhiman, N., Kharkwal, H., et al. (2023). Diagnosis and clinical aspects of lung cancer: a special emphasis on drug targeting to cancer cells through nanoparticles. Letters in Drug Design & Discovery, 20( 5), 499-516. doi:10.2174/1570180819666220510133408
NLM
Awasthi R, Singh AK, Mishra G, Maurya A, Dhiman N, Kharkwal H, Sharma B, Jha NK, Dua K, Pinto T de JA, Kulkarni GT. Diagnosis and clinical aspects of lung cancer: a special emphasis on drug targeting to cancer cells through nanoparticles [Internet]. Letters in Drug Design & Discovery. 2023 ; 20( 5): 499-516.[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/1570180819666220510133408
Vancouver
Awasthi R, Singh AK, Mishra G, Maurya A, Dhiman N, Kharkwal H, Sharma B, Jha NK, Dua K, Pinto T de JA, Kulkarni GT. Diagnosis and clinical aspects of lung cancer: a special emphasis on drug targeting to cancer cells through nanoparticles [Internet]. Letters in Drug Design & Discovery. 2023 ; 20( 5): 499-516.[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/1570180819666220510133408
Editor de periodico
Current Topics in Medicinal Chemistry (2023)
Zhou, Jia (Editor); Andricopulo, Adriano Defini (Editor) ; Ferreira, Leonardo Luiz Gomes (Editor) ; Garcia, Célia Regina da Silva (Editor)
Unidades: IFSC, FCF
Assunto: QUÍMICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
Current Topics in Medicinal Chemistry. . Sharjah: Bentham Science. . Acesso em: 28 abr. 2024. , 2023
APA
Current Topics in Medicinal Chemistry. (2023). Current Topics in Medicinal Chemistry. Sharjah: Bentham Science.
NLM
Current Topics in Medicinal Chemistry. 2023 ;[citado 2024 abr. 28 ]
Vancouver
Current Topics in Medicinal Chemistry. 2023 ;[citado 2024 abr. 28 ]
Artigo de periodico
Cruzain inhibitors: state-of-art of novel synthetic strategies (2023)
Morais, Pedro Alves Bezerra ; Trossini, Gustavo Henrique Goulart
Source: Current Organic Chemistry. Unidade: FCF
Subjects: DOENÇA DE CHAGAS, SÍNTESE ORGÂNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORAIS, Pedro Alves Bezerra e TROSSINI, Gustavo Henrique Goulart. Cruzain inhibitors: state-of-art of novel synthetic strategies. Current Organic Chemistry, v. 27, n. 4, p. 243-247, 2023Tradução . . Disponível em: https://doi.org/10.2174/1385272827666230418100932. Acesso em: 28 abr. 2024.
APA
Morais, P. A. B., & Trossini, G. H. G. (2023). Cruzain inhibitors: state-of-art of novel synthetic strategies. Current Organic Chemistry, 27( 4), 243-247. doi:10.2174/1385272827666230418100932
NLM
Morais PAB, Trossini GHG. Cruzain inhibitors: state-of-art of novel synthetic strategies [Internet]. Current Organic Chemistry. 2023 ; 27( 4): 243-247.[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/1385272827666230418100932
Vancouver
Morais PAB, Trossini GHG. Cruzain inhibitors: state-of-art of novel synthetic strategies [Internet]. Current Organic Chemistry. 2023 ; 27( 4): 243-247.[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/1385272827666230418100932
Artigo de periodico
Calotropis procera (Aiton) Dryand (Apocynaceae): state of the art of its use and applications (2023)
Rabelo, Ana Carolina Silveira ; Noratto, Giuliana D ; Borghesi, Jéssica ; Fonseca, Adriano Souza; Cantanhede Filho, Antônio José ; Carneiro, Fernando José Costa; Silva, Ana Lúcia Abreu ; Miglino, Maria Angélica
Source: Current Topics in Medicinal Chemistry. Unidades: FMVZ, FCF
Subjects: PLANTAS MEDICINAIS, MEDICINA ALTERNATIVA, FITOQUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RABELO, Ana Carolina Silveira et al. Calotropis procera (Aiton) Dryand (Apocynaceae): state of the art of its use and applications. Current Topics in Medicinal Chemistry, v. 23, n. 23, p. 2197-2213, 2023Tradução . . Disponível em: https://doi.org/10.2174/1568026623666230606162556. Acesso em: 28 abr. 2024.
APA
Rabelo, A. C. S., Noratto, G. D., Borghesi, J., Fonseca, A. S., Cantanhede Filho, A. J., Carneiro, F. J. C., et al. (2023). Calotropis procera (Aiton) Dryand (Apocynaceae): state of the art of its use and applications. Current Topics in Medicinal Chemistry, 23( 23), 2197-2213. doi:10.2174/1568026623666230606162556
NLM
Rabelo ACS, Noratto GD, Borghesi J, Fonseca AS, Cantanhede Filho AJ, Carneiro FJC, Silva ALA, Miglino MA. Calotropis procera (Aiton) Dryand (Apocynaceae): state of the art of its use and applications [Internet]. Current Topics in Medicinal Chemistry. 2023 ; 23( 23): 2197-2213.[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/1568026623666230606162556
Vancouver
Rabelo ACS, Noratto GD, Borghesi J, Fonseca AS, Cantanhede Filho AJ, Carneiro FJC, Silva ALA, Miglino MA. Calotropis procera (Aiton) Dryand (Apocynaceae): state of the art of its use and applications [Internet]. Current Topics in Medicinal Chemistry. 2023 ; 23( 23): 2197-2213.[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/1568026623666230606162556
Artigo de periodico-carta/editorial
Therapeutic potential of flavonoid derivatives for certain neglected tropical diseases [Editorial] (2022)
Pone, Boniface Kamdem ; Ferreira, Elizabeth Igne
Source: Current Drug Targets. Unidade: FCF
Subjects: FLAVONOIDES, MEDICAMENTO, DOENÇAS NEGLIGENCIADAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PONE, Boniface Kamdem e FERREIRA, Elizabeth Igne. Therapeutic potential of flavonoid derivatives for certain neglected tropical diseases [Editorial]. Current Drug Targets. Sharjah: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://doi.org/10.2174/1389450123666220309093827. Acesso em: 28 abr. 2024. , 2022
APA
Pone, B. K., & Ferreira, E. I. (2022). Therapeutic potential of flavonoid derivatives for certain neglected tropical diseases [Editorial]. Current Drug Targets. Sharjah: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.2174/1389450123666220309093827
NLM
Pone BK, Ferreira EI. Therapeutic potential of flavonoid derivatives for certain neglected tropical diseases [Editorial] [Internet]. Current Drug Targets. 2022 ; 23( 7): 680-682.[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/1389450123666220309093827
Vancouver
Pone BK, Ferreira EI. Therapeutic potential of flavonoid derivatives for certain neglected tropical diseases [Editorial] [Internet]. Current Drug Targets. 2022 ; 23( 7): 680-682.[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/1389450123666220309093827
Artigo de periodico
Contribution of transcriptome to elucidate the biology of Plasmodium spp (2022)
Parreira, Kleber Simônio; Scarpelli, Pedro; Lima, Wânia Rezende; Garcia, Célia Regina da Silva
Source: Current Topics in Medicinal Chemistry. Unidade: FCF
Subjects: PLASMODIUM, MALÁRIA, RNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARREIRA, Kleber Simônio et al. Contribution of transcriptome to elucidate the biology of Plasmodium spp. Current Topics in Medicinal Chemistry, v. 22, p. 169-187, 2022Tradução . . Disponível em: https://doi.org/10.2174/1568026622666220111140803. Acesso em: 28 abr. 2024.
APA
Parreira, K. S., Scarpelli, P., Lima, W. R., & Garcia, C. R. da S. (2022). Contribution of transcriptome to elucidate the biology of Plasmodium spp. Current Topics in Medicinal Chemistry, 22, 169-187. doi:10.2174/1568026622666220111140803
NLM
Parreira KS, Scarpelli P, Lima WR, Garcia CR da S. Contribution of transcriptome to elucidate the biology of Plasmodium spp [Internet]. Current Topics in Medicinal Chemistry. 2022 ; 22 169-187.[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/1568026622666220111140803
Vancouver
Parreira KS, Scarpelli P, Lima WR, Garcia CR da S. Contribution of transcriptome to elucidate the biology of Plasmodium spp [Internet]. Current Topics in Medicinal Chemistry. 2022 ; 22 169-187.[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/1568026622666220111140803
Artigo de periodico
Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development (2022)
Pone, Kamdem Boniface ; Dalhatou, Sadou; Paumo, Hugues Kamdem ; Seru, Lebogang Maureen Katata ; Ferreira, Elizabeth Igne
Source: Current Drug Targets. Unidade: FCF
Subjects: TRYPANOSOMA CRUZI, COMPOSTOS HETEROCÍCLICOS, ANTIPROTOZOÁRIOS, DOENÇAS NEGLIGENCIADAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PONE, Kamdem Boniface et al. Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development. Current Drug Targets, v. 23, n. 1, p. 33-59, 2022Tradução . . Disponível em: https://doi.org/10.2174/1389450122666210412125643. Acesso em: 28 abr. 2024.
APA
Pone, K. B., Dalhatou, S., Paumo, H. K., Seru, L. M. K., & Ferreira, E. I. (2022). Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development. Current Drug Targets, 23( 1), 33-59. doi:10.2174/1389450122666210412125643
NLM
Pone KB, Dalhatou S, Paumo HK, Seru LMK, Ferreira EI. Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development [Internet]. Current Drug Targets. 2022 ; 23( 1): 33-59.[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/1389450122666210412125643
Vancouver
Pone KB, Dalhatou S, Paumo HK, Seru LMK, Ferreira EI. Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development [Internet]. Current Drug Targets. 2022 ; 23( 1): 33-59.[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/1389450122666210412125643
Artigo de periodico
Zika virus NS2B-NS3 protease: quantum chemical properties insights into designing inhibitory peptides (2022)
Silva, João Vitor da ; Savino, Débora Feliciano; Hirata, Mario Hiroyuki ; Ferreira, Glaucio Monteiro ; Giarolla, Jeanine
Source: Protein and Peptide Letters. Unidade: FCF
Subjects: ZIKA VÍRUS, PEPTÍDEOS, MODELAGEM MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, João Vitor da et al. Zika virus NS2B-NS3 protease: quantum chemical properties insights into designing inhibitory peptides. Protein and Peptide Letters, v. 29, p. 901-910, 2022Tradução . . Disponível em: https://doi.org/10.2174/0929866529666220919143316. Acesso em: 28 abr. 2024.
APA
Silva, J. V. da, Savino, D. F., Hirata, M. H., Ferreira, G. M., & Giarolla, J. (2022). Zika virus NS2B-NS3 protease: quantum chemical properties insights into designing inhibitory peptides. Protein and Peptide Letters, 29, 901-910. doi:10.2174/0929866529666220919143316
NLM
Silva JV da, Savino DF, Hirata MH, Ferreira GM, Giarolla J. Zika virus NS2B-NS3 protease: quantum chemical properties insights into designing inhibitory peptides [Internet]. Protein and Peptide Letters. 2022 ; 29 901-910.[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/0929866529666220919143316
Vancouver
Silva JV da, Savino DF, Hirata MH, Ferreira GM, Giarolla J. Zika virus NS2B-NS3 protease: quantum chemical properties insights into designing inhibitory peptides [Internet]. Protein and Peptide Letters. 2022 ; 29 901-910.[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/0929866529666220919143316
Artigo de periodico
The role of nitro (NO 2-), Chloro (Cl), and Fluoro (F) substitution in the design of antileishmanial and antichagasic compounds (2021)
Boniface, Pone Kamdem ; Ferreira, Elizabeth Igne
Source: Current Drug Targets. Unidade: FCF
Subjects: DOENÇAS NEGLIGENCIADAS, ANTIMALÁRICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONIFACE, Pone Kamdem e FERREIRA, Elizabeth Igne. The role of nitro (NO 2-), Chloro (Cl), and Fluoro (F) substitution in the design of antileishmanial and antichagasic compounds. Current Drug Targets, v. 22, p. 379-398, 2021Tradução . . Disponível em: https://doi.org/10.2174/1389450121666201228122239. Acesso em: 28 abr. 2024.
APA
Boniface, P. K., & Ferreira, E. I. (2021). The role of nitro (NO 2-), Chloro (Cl), and Fluoro (F) substitution in the design of antileishmanial and antichagasic compounds. Current Drug Targets, 22, 379-398. doi:10.2174/1389450121666201228122239
NLM
Boniface PK, Ferreira EI. The role of nitro (NO 2-), Chloro (Cl), and Fluoro (F) substitution in the design of antileishmanial and antichagasic compounds [Internet]. Current Drug Targets. 2021 ; 22 379-398.[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/1389450121666201228122239
Vancouver
Boniface PK, Ferreira EI. The role of nitro (NO 2-), Chloro (Cl), and Fluoro (F) substitution in the design of antileishmanial and antichagasic compounds [Internet]. Current Drug Targets. 2021 ; 22 379-398.[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/1389450121666201228122239
Artigo de periodico
Insights into newly approved drugs from a medicinal chemistry perspective (2021)
Lima, Elys Juliane Cardoso ; Gomes, Renan Augusto ; Fornari, Evelin; Emery, Flavio da Silva ; Trossini, Gustavo Henrique Goulart
Source: Mini-Reviews in Medicinal Chemistry. Unidades: FCFRP, FCF
Assunto: FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Elys Juliane Cardoso et al. Insights into newly approved drugs from a medicinal chemistry perspective. Mini-Reviews in Medicinal Chemistry, v. 21, n. 16, p. 2227-2248, 2021Tradução . . Disponível em: https://doi.org/10.2174/1389557521666210226145328. Acesso em: 28 abr. 2024.
APA
Lima, E. J. C., Gomes, R. A., Fornari, E., Emery, F. da S., & Trossini, G. H. G. (2021). Insights into newly approved drugs from a medicinal chemistry perspective. Mini-Reviews in Medicinal Chemistry, 21( 16), 2227-2248. doi:10.2174/1389557521666210226145328
NLM
Lima EJC, Gomes RA, Fornari E, Emery F da S, Trossini GHG. Insights into newly approved drugs from a medicinal chemistry perspective [Internet]. Mini-Reviews in Medicinal Chemistry. 2021 ; 21( 16): 2227-2248.[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/1389557521666210226145328
Vancouver
Lima EJC, Gomes RA, Fornari E, Emery F da S, Trossini GHG. Insights into newly approved drugs from a medicinal chemistry perspective [Internet]. Mini-Reviews in Medicinal Chemistry. 2021 ; 21( 16): 2227-2248.[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/1389557521666210226145328
Artigo de periodico-carta/editorial
Receptors in health and diseases: purinergic signaling in parasites [Editorial] (2021)
Garcia, Célia Regina da Silva ; Silva, Robson Coutinho
Source: Current Topics in Medicinal Chemistry. Unidade: FCF
Subjects: RECEPTORES, MEDICAMENTO, NUCLEOTÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GARCIA, Célia Regina da Silva e SILVA, Robson Coutinho. Receptors in health and diseases: purinergic signaling in parasites [Editorial]. Current Topics in Medicinal Chemistry. Sharjah: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://doi.org/10.2174/156802662103210101154231. Acesso em: 28 abr. 2024. , 2021
APA
Garcia, C. R. da S., & Silva, R. C. (2021). Receptors in health and diseases: purinergic signaling in parasites [Editorial]. Current Topics in Medicinal Chemistry. Sharjah: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.2174/156802662103210101154231
NLM
Garcia CR da S, Silva RC. Receptors in health and diseases: purinergic signaling in parasites [Editorial] [Internet]. Current Topics in Medicinal Chemistry. 2021 ; 21( 3): 169-170.[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/156802662103210101154231
Vancouver
Garcia CR da S, Silva RC. Receptors in health and diseases: purinergic signaling in parasites [Editorial] [Internet]. Current Topics in Medicinal Chemistry. 2021 ; 21( 3): 169-170.[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/156802662103210101154231
Artigo de periodico
Evidences of G-Coupled Protein Receptor (GPCR) signaling in the human malaria parasite Plasmodium falciparum for sensing its microenvironment and the role of purinergic signaling in malaria parasites (2021)
Pereira, Pedro Henrique Scarpelli; Pereira, Lucas Borges; Garcia, Célia Regina da Silva
Source: Current Topics in Medicinal Chemistry. Unidade: FCF
Subjects: PLASMODIUM FALCIPARUM, MALÁRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Pedro Henrique Scarpelli e PEREIRA, Lucas Borges e GARCIA, Célia Regina da Silva. Evidences of G-Coupled Protein Receptor (GPCR) signaling in the human malaria parasite Plasmodium falciparum for sensing its microenvironment and the role of purinergic signaling in malaria parasites. Current Topics in Medicinal Chemistry, v. 21, p. 171-180, 2021Tradução . . Disponível em: https://doi.org/10.2174/1568026620666200826122716. Acesso em: 28 abr. 2024.
APA
Pereira, P. H. S., Pereira, L. B., & Garcia, C. R. da S. (2021). Evidences of G-Coupled Protein Receptor (GPCR) signaling in the human malaria parasite Plasmodium falciparum for sensing its microenvironment and the role of purinergic signaling in malaria parasites. Current Topics in Medicinal Chemistry, 21, 171-180. doi:10.2174/1568026620666200826122716
NLM
Pereira PHS, Pereira LB, Garcia CR da S. Evidences of G-Coupled Protein Receptor (GPCR) signaling in the human malaria parasite Plasmodium falciparum for sensing its microenvironment and the role of purinergic signaling in malaria parasites [Internet]. Current Topics in Medicinal Chemistry. 2021 ; 21 171-180.[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/1568026620666200826122716
Vancouver
Pereira PHS, Pereira LB, Garcia CR da S. Evidences of G-Coupled Protein Receptor (GPCR) signaling in the human malaria parasite Plasmodium falciparum for sensing its microenvironment and the role of purinergic signaling in malaria parasites [Internet]. Current Topics in Medicinal Chemistry. 2021 ; 21 171-180.[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/1568026620666200826122716
Artigo de periodico
Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis (2021)
Primi, Marina Candido ; Tavares, Maurício Temotheo ; Klein, Larry L; Izard, Tina; Sant'Anna, Carlos M. R; Franzblau, Scott Gary; Ferreira, Elizabeth Igne
Source: Current Topics in Medicinal Chemistry. Unidade: FCF
Subjects: TUBERCULOSE, ANTIBIÓTICOS, INIBIDORES DE ENZIMAS, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRIMI, Marina Candido et al. Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis. Current Topics in Medicinal Chemistry, v. 21, p. 1186-1197, 2021Tradução . . Disponível em: https://doi.org/10.2174/1568026621666210728094804. Acesso em: 28 abr. 2024.
APA
Primi, M. C., Tavares, M. T., Klein, L. L., Izard, T., Sant'Anna, C. M. R., Franzblau, S. G., & Ferreira, E. I. (2021). Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis. Current Topics in Medicinal Chemistry, 21, 1186-1197. doi:10.2174/1568026621666210728094804
NLM
Primi MC, Tavares MT, Klein LL, Izard T, Sant'Anna CMR, Franzblau SG, Ferreira EI. Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis [Internet]. Current Topics in Medicinal Chemistry. 2021 ; 21 1186-1197.[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/1568026621666210728094804
Vancouver
Primi MC, Tavares MT, Klein LL, Izard T, Sant'Anna CMR, Franzblau SG, Ferreira EI. Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis [Internet]. Current Topics in Medicinal Chemistry. 2021 ; 21 1186-1197.[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/1568026621666210728094804
Artigo de periodico
Synthesis and anticancer properties of ‘azole’ based chemotherapeutics as emerging chemical moieties: a comprehensive review (2021)
Prasher, Parteek ; Sharma, Mousmee ; Zacconi, Flavia ; Gupt, Gaurav ; Aljabali, Alaa A ; Mishra, Vijay ; Tambuwala, Murtaza M ; Kapoor, Deepak N ; Negi, Poonam ; Pinto, Terezinha de Jesus Andreoli ; Singh, Inderbir ; Chellappan, Dinesh Kumar ; Dua, Kamal
Source: Current Organic Chemistry. Unidade: FCF
Subjects: QUIMIOTERÁPICOS, COMPOSTOS HETEROCÍCLICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRASHER, Parteek et al. Synthesis and anticancer properties of ‘azole’ based chemotherapeutics as emerging chemical moieties: a comprehensive review. Current Organic Chemistry, v. 25, p. 654-668, 2021Tradução . . Disponível em: https://doi.org/10.2174/1385272824999200820152501. Acesso em: 28 abr. 2024.
APA
Prasher, P., Sharma, M., Zacconi, F., Gupt, G., Aljabali, A. A., Mishra, V., et al. (2021). Synthesis and anticancer properties of ‘azole’ based chemotherapeutics as emerging chemical moieties: a comprehensive review. Current Organic Chemistry, 25, 654-668. doi:10.2174/1385272824999200820152501
NLM
Prasher P, Sharma M, Zacconi F, Gupt G, Aljabali AA, Mishra V, Tambuwala MM, Kapoor DN, Negi P, Pinto T de JA, Singh I, Chellappan DK, Dua K. Synthesis and anticancer properties of ‘azole’ based chemotherapeutics as emerging chemical moieties: a comprehensive review [Internet]. Current Organic Chemistry. 2021 ; 25 654-668.[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/1385272824999200820152501
Vancouver
Prasher P, Sharma M, Zacconi F, Gupt G, Aljabali AA, Mishra V, Tambuwala MM, Kapoor DN, Negi P, Pinto T de JA, Singh I, Chellappan DK, Dua K. Synthesis and anticancer properties of ‘azole’ based chemotherapeutics as emerging chemical moieties: a comprehensive review [Internet]. Current Organic Chemistry. 2021 ; 25 654-668.[citado 2024 abr. 28 ] Available from: https://doi.org/10.2174/1385272824999200820152501

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Grupo de pesquisa

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration